ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Janssen's Tremfya gets go-ahead from NICE in plaque psoriasis
pharmafile
May 15, 2018NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the health service in the treatment of plaque psoriasis, having judged it an efficient use of financial resources.
Pharma Sources Insight January 2025
